Report ID: 10082384 |
Published Date: 21 Mar 2025 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Global Hemostasis and Tissue Sealing Agents Market Highlights Over 2022 - 2031
The global hemostasis and tissue sealing agents market garnered revenue of approximately USD 2,700 million by the end of the year 2021. The market is anticipated to grow at a CAGR of ~7% over the forecast period, i.e., 2022– 2031. The growth of the market can be attributed to increasing injuries and accidents with people that lead to severe blood loss. Approximately 300 million surgeries are executed every year globally. Around 40 – 50 million surgeries are performed in the U.S. and 20 million in the European region. Additionally, most of the rising old age population is suffering from different chronic diseases that create a need for surgery which further raises demand for the product.
CLICK TO DOWNLOAD SAMPLE REPORT
Furthermore, an increase in product approvals by regulatory bodies is expected to bolster the growth of the market. These products are extensively used in the medical and healthcare service sector and are used to stop bleeding which can be done mechanically or by increasing the coagulation cascade. These devices bind and heal the defects in the tissues of the patient’s body at the bleeding spot. These agents have a wide range of suitability as these products can be used in endoscopic procedures as well as urological treatments. Medical advancements as well as research & development in the field of healthcare sector are expected to proper the market growth. However, exorbitant surgical procedures as well as insufficient reimbursements for these products are expected to hinder the growth of the market.
On the basis of product type, the market is segmented into topical hemostats, adhesive and tissue sealing agents, out of which, the topical hemostats segment is estimated to hold the largest share of the market during the forecast period owing to factors such as quick blood absorbability as well as lesser tissue reactivity. Additionally, it has fast healing properties which promote platelet activation to form clotting matrix at the bleeding spot.
Global Hemostasis and Tissue Sealing Agents Market Regional Synopsis
Regionally, the global hemostasis and tissue sealing agents market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in North America region is estimated to witness noteworthy growth over the forecast period on the back of factors, such as the rising number of chronic diseases that require serious surgeries. The U.S. is suffering from an epidemic where around 50% of the total population has been distressed with some kind of chronic disease. Besides these, frequent cases of injuries and accidents in the U.S. and Canada as well as active investments by key players in the medical product pipeline development are expected to contribute towards the market growth.
Market Segmentation
Our in-depth analysis of the global hemostasis and tissue sealing agents market includes the following segments:
By Product Type
- Topical Hemostats
-
Active Hemostats
-
Mechanical Hemostats
-
Flowable Hemostats
-
Fibrin Sealants
-
Topical Thrombin Products
-
- Adhesive
-
Synthetic
-
Natural
-
Adhesion Barrier
-
- Tissue Sealant
By Material Type
-
Collagen Based
-
Gelatin Based
-
Oxidized Regenerated Cellulose (ORC) Based
-
Polysaccharide Based
-
Others
By End-User
-
Hospitals
-
Ambulatory Surgical Centers
-
Home Care Settings
-
Others
Growth Drivers and Challenges Impacting the Growth of the Global Hemostasis and Tissue Sealing Agents Market
Growth Drivers
-
Increasing number of surgical procedures worldwide
-
Growing medical advancements in the field of healthcare services
Challenges
-
High price of surgeries
-
Insufficient reimbursements for these products
Key Companies Dominating the Global Hemostasis and Tissue Sealing Agents Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global hemostasis and tissue sealing agents market that are included in our report are Pfizer Inc., Zimmer Biomet., Johnson& Johnson Services, Inc., CryoLife, Inc., Baxter International, Inc., Medtronic plc, B. Braun Melsungen AG, Integra LifeSciences, Stryker, Advanced Medical Solutions Group plc, and others.
Latest Developments in the Global Hemostasis and Tissue Sealing Agents Market:
-
July 2021: Baxter International, Inc., a leading manufacturer of medical devices proclaimed the acquisition of CryoLife, Inc.’s assets related to PerClot Polysaccharide Hemostatic System. This acquisition is aimed at strengthening the company’s portfolio and is expected to produce high-profit margins.
-
November 2020: Advanced Medical Solutions Group plc has acquired Raleigh Adhesive Coatings Limited, wound care, and biotechnology company that dealt in tissue sealing agents devices. This acquisition by the company is aimed at enhanced earnings as well as working towards commercial market opportunities. It will also help in better research and development in the arena of healthcare-related products and devices.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis, and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
Frequently Asked Question
The market is segmented by product type, material type, end user and by region.
The topical hemostats segment is anticipated to hold largest market size in value and is estimated to grow over the forecast period and display significant growth opportunities.
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10082384 |
Published Date: 21 Mar 2025 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
